Ruka hadi maudhui makuu

Condition · 2 treatment paths

Acute Myeloid Leukemia (AML)

Acute myeloid leukaemia is a fast-moving cancer of the bone marrow in which abnormal immature cells crowd out normal blood cells. It mainly affects adults, and the risk rises with age.

Severe
Request opinion View roster

Send your imaging + plan. Board-reviewed opinion in 5–10 working days.

Ilisasishwa mwisho: Jinsi tunavyokusanya na kukagua taarifa

Linear accelerator used for radiotherapy in a cancer treatment room
Treatment paths
2Treatment paths
Specialties
1Specialties
Typical severity
SevereTypical severity

About acute myeloid leukemia (aml)

What to know

Tiredness, breathlessness, infections, bleeding and bruising are common, as healthy blood cells fall. Diagnosis needs blood tests and a bone marrow biopsy, with cytogenetic and molecular tests that classify the subtype and predict response. These results decide treatment intensity, and outlook varies widely with genetic risk and age.

Fit patients receive intensive induction chemotherapy to reach remission, then consolidation chemotherapy or an allogeneic stem cell transplant, usually for intermediate- or high-risk disease. Targeted drugs are added for specific mutations, and older or less fit patients may have gentler combinations. Treatment abroad is usually considered for transplant, with a matched donor and a long period of follow-up in mind.

Pre-flight workup

Tests to have already done

  • Bone marrow biopsy and flow cytometry reports confirming AML and its subtype.
  • Cytogenetics and molecular panel results such as FLT3, NPM1, IDH1/2 and TP53, which define risk and targeted drug options.
  • Full blood counts and the date of diagnosis, with any infections or transfusions since.
  • Chemotherapy record showing the regimen, dates and remission status after induction.
  • HLA typing of you and any siblings, and donor search results if transplant is planned.

Second opinion

When to get a second look

  • Genetic testing was not completed and treatment was chosen without knowing the FLT3, NPM1 or TP53 status.
  • You are in remission and uncertain whether to proceed to allogeneic transplant now or watch.
  • The leukaemia is refractory to treatment or has relapsed.
  • You are older or have other illnesses and have been offered only palliative treatment.

Talking to your doctor

Questions to ask

  1. What is my genetic risk group, and what does it mean for treatment?
  2. Should I have a stem cell transplant in first remission, and how was that decided?
  3. Are there targeted drugs for my mutations?
  4. What are the risks of infection, graft-versus-host disease and relapse after transplant?
  5. How will my remission be checked, and how often?
  6. What happens to me if I cannot have intensive treatment?

Outlook

Realistic prognosis

AML can be cured in some people, particularly younger patients with favourable genetics, but relapse is a real risk. Many adults reach remission with chemotherapy, and an allogeneic transplant improves the chance of lasting remission in intermediate and high-risk disease. Age, other illnesses, mutation profile and response to induction chemotherapy are the main factors determining the outcome.

01 · Specialties

Specialties that treat Acute

Specialists Doctors who treat acute myeloid leukemia (aml) Cross-hospital roster across 1+ relevant specialties. View roster

Diagnostic workup

Before you pick a hospital, get the workup right

Severe — workup typically within 48–72 hours

Picking the right treatment is downstream of a complete diagnosis. Skip steps here and the destination surgeon usually re-orders them anyway — at higher cost and another week on the ground.

  1. Confirm the diagnosis on imaging or labs

    For acute myeloid leukemia (aml), plan on the workup your home doctor would order anyway — typically a recent specialist consult plus the imaging / labs the destination team will need to quote accurately. Anything older than 90 days usually gets re-done.
  2. See a oncology specialist locally first

    An in-person clinical exam at home — even a single consult — costs little and dramatically improves the destination plan. Bring back: written impression, recommended procedure, surgical-risk class, and any contra-indications.
  3. Send us the file for a free second opinion

    Two surgeons in our medical panel review the workup independently. They tell you whether they'd operate, watch, or refer — even if that means recommending against travel.
  4. Pick a path with timeline + cost in writing

    Once a treatment is the right call, we line up 2–3 hospital options with itemized quotes, surgeon profiles, and a travel timeline. You hold the file — switch hospitals or step away at any point.

03 · Treatment paths

Treatment options

All treatments

Where to be treated

Acute Myeloid Leukemia (AML) treatment by destination

Get a panel match

04 · FAQ

Common questions about acute myeloid leukemia (aml)

Does everyone with AML need a transplant?

No. Transplant is generally recommended for intermediate- and high-risk disease in fit patients, while favourable-risk disease may be treated with chemotherapy alone.

Can AML be cured?

Yes, in a proportion of patients, particularly younger people with favourable genetics. Relapse is the main risk and is monitored with regular blood and marrow tests.

How long will I be in hospital?

Intensive chemotherapy usually needs several weeks in hospital for each major cycle because of infection risk. Transplant involves a longer stay and months of close follow-up.

Clinical context

Working up acute myeloid leukemia (aml) properly

A condition like acute myeloid leukemia (aml) is rarely well-served by jumping straight to treatment shopping. The sequence below is what a oncology specialist would expect to see completed — and the absence of any step is the right cue to delay travel decisions.

Diagnostic workup, in sequence

  1. First-line clinical assessment

    History, physical exam, and risk-factor review by a senior generalist or oncology specialist. Symptoms list, family history, prior workup notes, and current medication list should travel with the patient.

  2. Standard imaging + labs

    Baseline blood work, condition-specific imaging (ultrasound / X-ray / MRI / CT — depending on indication), and ECG / pulmonary function as relevant. Bring digital copies of any prior imaging — saves repeat scans and the cost that goes with them.

  3. Specialist diagnostic workup

    Procedure-specific tests — biopsy, cardiac catheterisation, endoscopy, or genetic / molecular profiling depending on the suspected diagnosis. Done at the centre that will treat, ideally, so results integrate cleanly into the treatment plan.

  4. Multidisciplinary review (where indicated)

    Cancer, complex cardiac, transplant, and rare-disease cases should be reviewed by a multidisciplinary panel — surgical, medical, imaging, and pathology — before any treatment commits. Single-discipline plans for complex disease are a quality red flag.

When to escalate urgently

  • Acute worsening of established symptoms — sudden chest pain, shortness of breath at rest, neurological deficit, severe bleeding, persistent high fever.
  • Loss of consciousness, severe persistent vomiting, or any focal neurological event.
  • Symptoms in the early hours of onset that fit a time-sensitive treatment window (stroke, MI, sepsis) — every hour costs outcome.
  • If you are travelling internationally for treatment and develop these symptoms in transit, divert to the nearest emergency department; do not wait to reach the planned destination.

Before you book international travel

  • Confirm your specific diagnosis is fully worked up before you commit to a treatment plan abroad. Travelling for the workup is fine; travelling for treatment without the workup done is not.
  • Get your case reviewed remotely by the destination centre's team before you book flights — credible international patient programs review imaging + reports before they confirm the surgical plan.
  • Bring a digital + physical copy of your full medical record: imaging on USB drive in DICOM format, labs in PDF, current medication list with dosages, allergies, and any prior surgical reports.
  • Plan for longer recovery + post-discharge therapy continuation before you fly — the surgery itself is rarely the bottleneck.
  • Confirm that follow-up imaging and any necessary in-person reviews can be done at home — a treatment plan that requires repeat international trips is more burdensome (and more expensive) than the headline procedure.
Jinsi ukurasa huu ulivyoandaliwa

Mbinu na viwango vya uhariri

This acute myeloid leukemia (aml) overview is written by the editorial team from published Oncology sources and lists 2 treatment options offered by hospitals on our network. The page shows its last-updated date. Clinical descriptions are editorial — your treating clinician confirms what's right for your specific case.

  1. Taarifa za hospitali. Maelezo ya hospitali yanakusanywa kutoka vyanzo vya umma na tovuti za hospitali. Uidhinishaji (JCI, NABH na mengine) huonyeshwa pale tulipo na rekodi. Daima omba hospitali cheti chake cha sasa.
  2. Sifa za madaktari. Sifa, utaalamu na wasifu hutoka wasifu wa daktari hospitalini. Leseni hukaguliwa kwenye rejista ya baraza la kitaifa la madaktari tu pale wasifu unapoonyesha alama ya "Leseni imehakikiwa" yenye tarehe.
  3. Bei. Viwango vya bei ni vya kukadiria, vimekusanywa kutoka orodha za bei na vifurushi vya hospitali na huonyeshwa na tarehe ya mwisho ya kusasishwa. Unacholipa ni kile kilichoandikwa kwenye nukuu ya hospitali.
  4. Maandishi ya kitabibu. Imeandikwa na timu ya wahariri ya Medcasts kutoka vyanzo vya kliniki vilivyochapishwa. Isipokuwa ukurasa umetaja mhakiki kwa jina, haujakaguliwa na daktari.
  5. Uhuru. Hospitali haziwezi kulipa ili kubadilisha nafasi yao kwenye kurasa zetu.
Vyanzo vya taarifa za ukurasa huu
Peer-reviewed clinical guidelines (NCCN, ESMO, ESC, AHA, NICE — by indication)WHO ICD-11 condition classificationNational medical society treatment protocolsJCI accreditation registry

Acute Myeloid Leukemia (AML)

Continue evaluating acute myeloid leukemia (aml) care

Condition overview is one entry. These hubs route the same care decision via specialty, surgeon, treatment, and destination — including the doctors actively treating acute myeloid leukemia (aml).

Hatua inayofuata · Acute Myeloid Leukemia (AML)

Free second opinion on your Acute case.

Share imaging and the current plan. Multidisciplinary board returns a written opinion within 5–10 working days — no obligation to travel.

Pata makadirio ya bei bureMakadirio ya kina kutoka hospitali zilizoidhinishwa, bila malipo Maoni ya pili ya daktari bureMtaalamu anapitia ripoti zako Ongea na mratibuWhatsApp, barua pepe au simu